JSR Corp.

Company Overview

JSR is a leading technology company using technological expertise cultivated by its founding and the power of diverse human resources worldwide. The corporation has three pillars: core Digital Solutions and Life Sciences businesses, as well as the Plastics business. On June 25, 2024, JSR made a new beginning by entering a strategic partnership with JIC Capital, Ltd. and delisting shares from the public stock market.

Using JSR’s polymer technology, JSR has expanded its business to semiconductors, displays, and optical materials. JSR is now developing the Life Sciences business as a new pillar by providing bioprocess and diagnostic materials and drug discovery and development services for biopharmaceuticals. JSR Life Sciences, LLC is a part of a corporation that discovers, develops, and delivers products to treat disease and improve the quality of life for patients. The JSR Life Sciences family includes MBL, Crown Bioscience, KBI Biopharma, Inc., Selexis SA, and other affiliates throughout Europe and the Asia-Pacific region.

Financial Highlights (FY 2024)

Company's Business Segments

• Digital Solutions : This segment includes Semiconductor Materials, Lithography Materials, Photoresists, Multilayer Materials, Cleans Advanced Packaging Materials, CMP Materials, Display Materials, Materials for Color LCDs, Materials for OLED.
• Life Sciences : This segment includes Diagnostic, Research Reagents and similar materials Bio-Process Materials, Services to Support Drug Development.
• Plastics : This segment includes Synthetic Resins including ABS Resins, AES Resins, AS Resins, ASA Resins.
• Other : The Other segment is a business segment not contained in the reportable segments. It includes the manufacturing and sale of chemicals such as adhesions and other businesses.